Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Sarcopenia 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neoplasms 1 Kidney Neoplasms 1 Food Preferences 1 Carcinoma, Renal Cell 1 Breast Neoplasms 1 Anosmia 1

Interventions

pembrolizumab 14 Nivolumab 11 Ipilimumab 10 cabozantinib 6 Axitinib 6 belzutifan 5 Radiosurgery 5 atezolizumab 4 Sunitinib 4 palbociclib 3 lenvatinib 3 Surveys and Questionnaires 3 Radiotherapy 3 Pluvicto 3 Everolimus 3 Blood Specimen Collection 3 Biopsy 3 zimberelimab 2 pazopanib 2 cemiplimab 2 Therapeutics 2 Methods 2 Magnetic Resonance Spectroscopy 2 Irinotecan 2 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 2 trebananib 1 toripalimab 1 tocilizumab 1 temsirolimus 1 spartalizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Kidney Neoplasms × Nutrition Therapy × 1 year × Clear all

NCT06903312 2025-07-03

ITALIC-RCC

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase 4 Recruiting

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡